Literature DB >> 12417381

Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease.

S Salloway1, T Gur, T Berzin, R Tavares, B Zipser, S Correia, V Hovanesian, J Fallon, V Kuo-Leblanc, D Glass, C Hulette, C Rosenberg, M Vitek, E Stopa.   

Abstract

APOE4 homozygosity has been associated with an increased risk of sporadic Alzheimer's disease through a mechanism, which has yet to be defined. Recent evidence has suggested that microvascular basement membrane injury may be a critical factor in the pathogenesis of AD-related dementia. In previous studies, we have shown that the synaptic organizing protein agrin can be found in neurons, and is a major component of the brain microvascular basement membrane. Here, we compare the basement membrane surface area of cortical microvasculature in AD brains by staining with an anti-agrin antibody. Quantitative morphometric analysis was used to determine the mean basement area (micro(2)) of prefrontal cortical microvessels. An average of 10 capillaries was measured in each of 35 cases of AD genotyped for APOE status. APOE4,4 homozygotes had smaller capillary basement membrane areas (17.4 micro(2))+/-6.2) than APOE3,3 homozygotes (26.9 micro(2)+/-6.5), p<0.001. The capillary basement membrane areas (CBMA) of heterozygotes APOE3,4 did not differ significantly from APOE3,3 or APOE4,4. Braak stage did not contribute significantly to CBMA. However, a preliminary analysis suggests an interaction between APOE4,4 and Braak V-VI producing smaller CBMA, a finding which needs to be confirmed with a larger sample. These data support the hypothesis that APOE4,4 is associated with thinning of the microvascular basement membrane in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417381     DOI: 10.1016/s0022-510x(02)00288-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  37 in total

1.  Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.

Authors:  Wael Alata; Yue Ye; Isabelle St-Amour; Milène Vandal; Frédéric Calon
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-22       Impact factor: 6.200

Review 2.  Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.

Authors:  Therese S Salameh; Elizabeth M Rhea; William A Banks; Angela J Hanson
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

3.  APOE4 Accelerates Development of Dementia After Stroke: Is There a Role for Cerebrovascular Dysfunction?

Authors:  Axel Montagne; Daniel A Nation; Berislav V Zlokovic
Journal:  Stroke       Date:  2020-02-18       Impact factor: 7.914

4.  Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.

Authors:  Steven M Rauch; Kathy Huen; Miles C Miller; Hira Chaudry; Melissa Lau; Joshua R Sanes; Conrad E Johanson; Edward G Stopa; Robert W Burgess
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

5.  A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.

Authors:  Melanie D Sweeney; Abhay P Sagare; Maricarmen Pachicano; Michael G Harrington; Elizabeth Joe; Helena C Chui; Lon S Schneider; Axel Montagne; John M Ringman; Anne M Fagan; John C Morris; Judy Pa; Daniel A Nation; Arthur W Toga; Berislav V Zlokovic
Journal:  Alzheimers Dement       Date:  2020-04-16       Impact factor: 21.566

6.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 7.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

8.  Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.

Authors:  Matthew R Halliday; Sanket V Rege; Qingyi Ma; Zhen Zhao; Carol A Miller; Ethan A Winkler; Berislav V Zlokovic
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 9.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

Review 10.  The pericyte: a forgotten cell type with important implications for Alzheimer's disease?

Authors:  Ethan A Winkler; Abhay P Sagare; Berislav V Zlokovic
Journal:  Brain Pathol       Date:  2014-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.